CDEK
← All drugs Report issue

Ibiglustat

Small moleculeexperimental

Clinical trial activity

6 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Aug 1, 2012 (NCT01674036)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • genz-682452
  • genz-682452
  • gz402671
  • gz402671
  • gz/sar402671

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02843035Phase 2Jan 4, 2017Genzyme, Sanofi
NCT02906020Phase 2Dec 15, 2016Genzyme, Sanofi
NCT02489344Phase 2Jul 1, 2015Genzyme, Sanofi
NCT02228460Phase 2Nov 1, 2014Genzyme, Sanofi
NCT01710826Phase 1Oct 1, 2012Genzyme
NCT01674036Phase 1Aug 1, 2012Genzyme
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GenzymeFor profit6622012
SanofiFor profit4012014
2 organizations
Page 1 / 1